Skip to content
Politically.com Search all
Menu

2025 · 2nd Quarter (Apr 1 - June 30)

KARDIOGENICS, INC.

Filed by TENAGRITY SOLUTIONS, LLC.

Open official filing
Source: Lobbying Disclosure APIRecently refreshed. 2026-08-03 06:26:15 UTC.

Source-reported fields

Filing overview

Type
2nd Quarter - Report
Posted
Jul 21, 2025
Income
Not reported
Expenses
Not reported
Filing UUID
208b4320-8926-4dfc-ad01-8006afab84f6
Termination date
Not reported

Literal source text

Lobbying issues and bill citations

DEF · Defense

Discussions with congressional offices and DoD re: client and how their product and work could save lives (including how they can help with defense); FY26 defense appropriations (H.R.4016), requests to ensure adequate funding to finalize development and distribution

Literal federal measure citations: H.R.4016

MED · Medical/Disease Research/Clinical Labs

Discussions with congressional offices and HHS re: client and how their product and work could save lives

HCR · Health Issues

Discussions with congressional offices, HHS, and DoD re: client and how their product and work could save lives (including how they can help with defense)

BUD · Budget/Appropriations

Discussions with congressional offices and DoD re: client and how their product and work could save lives (including how they can help with defense); FY26 defense appropriations (H.R.4016) requests to ensure adequate funding to finalize development and distribution

Literal federal measure citations: H.R.4016

Relationship and amount limits

Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.